New York, New York (PRWEB) July 14, 2012
Sports Nutrition Research, purveyors of the testosterone-boosting compound ProLensis, has announced that a human safety study using the extract is to be published. Bulbine natalensis is a plant indigenous to Africa, traditionally used as an aphrodisiac and tonic in tribesmen. ProLensis is a well-studied specific extract of bulbine natalensis, with several animal model studies demonstrating the benefit for controlling the hormones testosterone and estrogen both hormones involved in body augmentation. These findings have since been reproduced in unpublished human studies, and today ProLensis features in some of the most popular testosterone-boosting dietary supplements available.
The human safety study, performed by The Center for Applied Health Sciences (CAHS) in Stow, Ohio, was a placebo-controlled, double-blind twenty-eight day trial involving thirty-six healthy adults. The values investigated by the researchers were clinical labs including renal, hepatic and haematological biomarkers. Also monitored were physical parameters, including heart rate, blood pressure and EKG. At the conclusion of the trial, ProLensis was found to be as safe as a maltodextrin placebo. This is an important finding for ProLensis as it provides the first peer-reviewed documentation of safety in humans.
The findings were presented at the recent International Society of Sports Nutrition (ISSN) conference held in Clearwater beach, Florida in June 2012. The results of the study are to be published in the highly esteemed scientific Journal of the International Society of Sports Nutrition (JISSN).
Sports Nutrition Research has also announced that there are plans for The Center for Applied Health Science to conduct more human trials involving ProLensis in the future.
Sports Nutrition Research is a raw materials provider and supplement formulation team that consults for several dietary supplement manufacturers. For more information about ProLensis or to order ProLensis for your own product line please visit http://www.ProLensis.com or contact info(at)ProLensis(dot)com.